Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen | Zendy

A Dorothee Heemskerk | Zendy; M. Nguyen | Zendy; Ha Thi Minh Dang | Zendy; Nguyễn Văn Vĩnh Châu | Zendy; Lan Huu Nguyen | Zendy; Thu Dang Anh | Zendy; Thuong Thuy Thuong Nguyen | Zendy; Marcel Wolbers | Zendy; Jeremy Day | Zendy; Lê Thị Phương Thảo | Zendy; Bang Nguyen | Zendy; Maxine Caws | Zendy; Guy Thwaites | Zendy

Open Access

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen

Author(s) -

A Dorothee Heemskerk,

M. Nguyen,

Ha Thi Minh Dang,

Nguyễn Văn Vĩnh Châu,

Lan Huu Nguyen,

Thu Dang Anh,

Thuong Thuy Thuong Nguyen,

Marcel Wolbers,

Jeremy Day,

Lê Thị Phương Thảo,

Bang Nguyen,

Maxine Caws,

Guy Thwaites

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix230

Subject(s) - medicine , regimen , tuberculous meningitis , meningitis , tuberculosis , drug , drug resistance , intensive care medicine , surgery , pharmacology , pathology , microbiology and biotechnology , biology

Drug-resistant tuberculous meningitis (TBM) is difficult to diagnose and treat. Mortality is high and optimal treatment is unknown. We compared clinical outcomes of drug-resistant and -susceptible TBM treated with either standard or intensified antituberculosis treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research